BRPI0816823A2 - Formulação contendo composto inibidor de quinase dependente de ciclina e método de tratamento de tumores que a utiliza - Google Patents

Formulação contendo composto inibidor de quinase dependente de ciclina e método de tratamento de tumores que a utiliza

Info

Publication number: BRPI0816823A2
Authority: BR; Brazil
Prior art keywords: treatment method; kinase inhibitor; formulation containing; containing composite; dependent kinase
Prior art date: 2007-09-17

Application number

BRPI0816823-7A2A

Other languages

English (en)

Inventor

Valentyn Antochshuk

Rajat Bannerji

Anita Dabbara

Paul Kirschmeier

David A Parry

Mohammed Shameem

Paul Statkevich

Siu-Long Yao

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-09-17

Filing date

2008-09-16

Publication date

2015-03-10

2008-09-16 Application filed by Schering Corp filed Critical Schering Corp

2015-03-10 Publication of BRPI0816823A2 publication Critical patent/BRPI0816823A2/pt

2016-02-10 Publication of BRPI0816823A8 publication Critical patent/BRPI0816823A8/pt

Links

206010028980 Neoplasm Diseases 0.000 title 1
239000002131 composite material Substances 0.000 title 1
230000001419 dependent effect Effects 0.000 title 1
238000009472 formulation Methods 0.000 title 1
229940043355 kinase inhibitor Drugs 0.000 title 1
238000000034 method Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 title 1
239000003757 phosphotransferase inhibitor Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Hematology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

BRPI0816823A 2007-09-17 2008-09-16 Formulação contendo composto inibidor de quinase dependente de ciclina e método de tratamento de tumores que a utiliza BRPI0816823A8 (pt)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US99418507P	2007-09-17	2007-09-17
US99946907P	2007-10-17	2007-10-17
US5378408P	2008-05-16	2008-05-16
PCT/US2008/010778 WO2009038701A2 (en)	2007-09-17	2008-09-16	Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same

Publications (2)

Publication Number	Publication Date
BRPI0816823A2 true BRPI0816823A2 (pt)	2015-03-10
BRPI0816823A8 BRPI0816823A8 (pt)	2016-02-10

Family

ID=40020243

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0816823A BRPI0816823A8 (pt)	2007-09-17	2008-09-16	Formulação contendo composto inibidor de quinase dependente de ciclina e método de tratamento de tumores que a utiliza

Country Status (12)

Country	Link
EP (1)	EP2200584A2 (pt)
JP (1)	JP2010539173A (pt)
KR (1)	KR20100072253A (pt)
CN (1)	CN101854915A (pt)
AU (1)	AU2008301925A1 (pt)
BR (1)	BRPI0816823A8 (pt)
CA (1)	CA2699761A1 (pt)
CO (1)	CO6270205A2 (pt)
MX (1)	MX2010002927A (pt)
NZ (1)	NZ584037A (pt)
SG (1)	SG184760A1 (pt)
WO (1)	WO2009038701A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2013541587A (ja) *	2010-11-05	2013-11-14	ミレニアムファーマシューティカルズ，インコーポレイテッド	Ｎｅｄｄ８活性化酵素阻害剤の投与
TWI679977B (zh) *	2011-10-19	2019-12-21	大塚製藥股份有限公司	口服溶液
AU2014309199B2 (en)	2013-08-20	2018-04-19	Merck Sharp & Dohme Llc	Treating cancer with a combination of a PD-1 antagonist and dinaciclib

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8673924B2 (en) *	2002-09-04	2014-03-18	Merck Sharp & Dohme Corp.	Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
US7119200B2 (en) *	2002-09-04	2006-10-10	Schering Corporation	Pyrazolopyrimidines as cyclin dependent kinase inhibitors

2008
- 2008-09-16 EP EP08831837A patent/EP2200584A2/en not_active Withdrawn
- 2008-09-16 CA CA2699761A patent/CA2699761A1/en not_active Abandoned
- 2008-09-16 BR BRPI0816823A patent/BRPI0816823A8/pt not_active IP Right Cessation
- 2008-09-16 CN CN200880116604A patent/CN101854915A/zh active Pending
- 2008-09-16 AU AU2008301925A patent/AU2008301925A1/en not_active Abandoned
- 2008-09-16 WO PCT/US2008/010778 patent/WO2009038701A2/en not_active Ceased
- 2008-09-16 MX MX2010002927A patent/MX2010002927A/es not_active Application Discontinuation
- 2008-09-16 SG SG2012068458A patent/SG184760A1/en unknown
- 2008-09-16 NZ NZ584037A patent/NZ584037A/xx not_active IP Right Cessation
- 2008-09-16 KR KR1020107008144A patent/KR20100072253A/ko not_active Withdrawn
- 2008-09-16 JP JP2010524891A patent/JP2010539173A/ja active Pending
2010
- 2010-03-25 CO CO10035469A patent/CO6270205A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2699761A1 (en)	2009-03-26
KR20100072253A (ko)	2010-06-30
SG184760A1 (en)	2012-10-30
WO2009038701A2 (en)	2009-03-26
MX2010002927A (es)	2010-06-01
EP2200584A2 (en)	2010-06-30
CN101854915A (zh)	2010-10-06
CO6270205A2 (es)	2011-04-20
AU2008301925A1 (en)	2009-03-26
NZ584037A (en)	2012-08-31
JP2010539173A (ja)	2010-12-16
WO2009038701A3 (en)	2009-09-11
BRPI0816823A8 (pt)	2016-02-10

Similar Documents

Publication	Publication Date	Title
HUS2200052I1 (hu)	2023-01-28	Imidazotriazinok és imidazopirimidinek mint kinázgátlók
BRPI1011505A2 (pt)	2016-03-22	formas de pró-drogas de inibidores de quinase e sua aplicação em terapia
FI20050867L (fi)	2007-03-01	Menetelmä ja kutsujärjestelmä
BRPI0915231A2 (pt)	2018-06-12	compostos inibidores de quinase e métodos de uso
FI20085839A0 (fi)	2008-09-08	Menetelmiä ja välineitä pehmytkudosteknologiaan
GB0625659D0 (en)	2007-01-31	Therapeutic compounds and their use
IL211549A0 (en)	2011-05-31	Aminotriazolopyridines and their use as kinase inhibitors
PL2037902T3 (pl)	2013-12-31	Zastosowanie kanabidiolu w użyciu w leczeniu bólu neuropatycznego
FI20075978A0 (fi)	2007-12-31	Järjestely ja menetelmä
ZA201004055B (en)	2012-09-26	4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors
CL2008000290A1 (es)	2008-09-05	Metodo para tratar un tumor que comprende un antagonista vegf y un inhibidor de proteina quinasa.
DK2358710T3 (da)	2012-09-03	AKT- og P70-S6-kinaseinhibitorer
PL2256063T3 (pl)	2015-09-30	Urządzenie rozpylające oraz sposób użycia urządzenia rozpylającego
FI20075881A0 (fi)	2007-12-05	Lääketieteellinen väline ja sen käyttö
HRP20192282T8 (hr)	2020-07-10	Inhibitori tfpi i postupci upotrebe
CL2011002569A1 (es)	2012-04-09	Procedimiento de tratamiento o prevencion que comprende administrar un inhibidor de tirosina cinasa y un inhibidor de igf-1r.
FI20060484L (fi)	2007-11-18	Lannoiterae ja menetelmä sen valmistamiseksi
BRPI0921888A2 (pt)	2015-12-29	terapia de combinação de inibidor de egfr inibidor da p70 s6 quinase
BRPI0816823A2 (pt)	2015-03-10	Formulação contendo composto inibidor de quinase dependente de ciclina e método de tratamento de tumores que a utiliza
ES2400375T8 (es)	2013-09-10	Combinación que comprende A) un compuesto de pirimidilaminobenzamida y B) un inhibidor de cinasa THR315ILE
WO2011046382A3 (en)	2011-10-06	Nrf2 inhibitors and use thereof
BRPI0815414A2 (pt)	2015-02-03	Marcador para o tratamento com inibidor de egfr
EP2224932A4 (en)	2011-09-14	TREATMENT OF CANCER USING A COMBINATION OF A COX-2 INHIBITOR AND AN ANTI-METABOLITE
NO20073364L (no)	2008-12-30	Ballasterbar oppdriftsanordning og anvendelse av denne
FI20060978A0 (fi)	2006-11-07	Stimulaatiomenetelmä ja -laitteisto

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 6A E 7A ANUIDADES. PAGAR RESTAURACAO.
2016-02-10	B25D	Requested change of name of applicant approved	Owner name: MERCK SHARP AND DOHME CORP. (US)
2016-02-23	B25G	Requested change of headquarter approved	Owner name: MERCK SHARP AND DOHME CORP. (US)
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.